(Q36427605)

14 August 2017

1 reference

title

Venous thromboembolism and anticoagulant therapy in pregnancy (English)

1 reference

14 August 2017

0 references

1 reference

venous thromboembolism

1 reference

1 reference

Ian A Greer

1

1 reference

14 August 2017

publication date

1 January 2005

1 reference

14 August 2017

1 reference

14 August 2017

volume

2 Suppl A

1 reference

14 August 2017

page(s)

S10-7

1 reference

Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Internal jugular vein thrombosis after assisted conception therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

The deep venous system in the puerperium: an ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Thrombosis in pregnancy: maternal and fetal issues

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

The warfarin embryopathy: a rat model showing maxillonasal hypoplasia and other skeletal disturbances

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Placental transport of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Tinzaparin sodium for thrombosis treatment and prevention during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Low molecular weight heparin in pregnancy: current issues

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2805%2980060-9

7 January 2021

10.1016/S1550-8579(05)80060-9

Identifiers

DOI

1 reference

14 August 2017

1 reference